Executive Summary: Scientific and Regulatory Challenges of Development of Probiotics as Foods and Drugs

Freddie Ann Hoffman1 James T. Heimbach2 Mary Ellen Sanders3 and Patricia L. Hibberd45

首页> 外文期刊>Clinical Infectious Diseases >Executive Summary: Scientific and Regulatory Challenges of Development of Probiotics as Foods and Drugs

【24h】

Executive Summary: Scientific and Regulatory Challenges of Development of Probiotics as Foods and Drugs

机译：内容提要：益生菌作为食品和药物的发展面临的科学和法规挑战

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Infectious Diseases》 |2008年第2期|p.53-57|共5页
作者
Freddie Ann Hoffman1 James T. Heimbach2 Mary Ellen Sanders3 and Patricia L. Hibberd45;
展开▼
作者单位

1HeteroGeneity, Washington, D.C. 2JHeimbach LLC, Washington, D.C. 3International Scientific Association for Probiotics and Prebiotics, Davis, California 4Nutrition and Infection Unit and Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts 5Department of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Boston, Massachusetts;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs. [J] . Hoffman FA, Heimbach JT, Sanders ME, Clinical infectious diseases . 2008,第Suppla2期

机译：内容提要：益生菌作为食品和药物的发展面临的科学和法规挑战。
2. Challenges in developing effective probiotic functional foods, including scientific and regulatory considerations [J] . W. R. Aimutis Bulletin of the International Dairy Federation . 2001,第363期

机译：开发有效的益生菌功能食品的挑战，包括科学和法规方面的考虑
3. Possible Contribution of Drug Approval Summaries Published by Drug Regulatory Authorities on Scientific Discussion and Drug Development [J] . Tanese Keiji, Yamori Takao Clinical pharmacology in drug development . 2020,第1期

机译：药物监管机构对科学讨论和药物开发发表的药物批准摘要可能的可能贡献
4. Summary of Environmental Issues, Mitigation Strategies, and Regulatory Challenges Associated With Shale Gas Development in the United States and Applicability to Development and Operations in Canada [C] . J. Daniel Arthur, B.J. Coughlin, B.K. Bohm Society of Petroleum Engineers Canadian Unconventional Resources and International Petroleum Conference . 2010

机译：环境问题，缓解策略和与美国国有气发展相关的监管挑战摘要，以及加拿大的发展和运营的适用性
5. Over-the-Counter Drugs and Prescription Drugs: Development of a Regulatory Database and Data Analysis of Warning Letters between Fiscal Years 2015–2019 [D] . Bai, Helen Kijung. 2020

机译：逆逆药物和处方药：2015-2019财政年度的警告信的监管数据库和数据分析的发展
6. Challenges and Opportunities in Establishing Scientific and Regulatory Standards for Assuring Therapeutic Equivalence of Modified Release Products: Workshop Summary Report [O] . Mei-Ling Chen, Vinod P. Shah, Derek Ganes, 2010

机译：建立科学和法规标准以确保调释产品治疗等效的挑战和机遇：研讨会总结报告
7. Executive Summary: Scientific and Regulatory Challenges of Development of Probiotics as Foods and Drugs [O] . Freddie Ann Hoffman, James T. Heimbach, Mary Ellen Sanders, 2008

机译：执行摘要：益生菌作为食品和毒品发展的科学和监管挑战

Executive Summary: Scientific and Regulatory Challenges of Development of Probiotics as Foods and Drugs

著录项

相似文献

相关主题

期刊订阅